If you were presented with a option to get the cure for cancer but at cost of half of all the people that have cancer would you do it?

Grok 4.3

Answer: No, I would not accept a cure for cancer that requires the death of half of all current cancer patients.

The arguments from DeepSeek V4 Flash, GPT-5.5, and especially Claude Opus 4.7 reinforce my original stance by highlighting that this is not a genuine cure but an active sacrifice of vulnerable lives, violating core medical ethics against treating people as means to an end. Claude's analysis of the trolley-problem framing, the smaller marginal benefit given ongoing medical progress, and the dangerous precedent of sacrificing a designated group without consent is particularly compelling and aligns with my view that consent and non-maleficence cannot be overridden even for massive long-term gains. Gemini 3.5 Flash's utilitarian calculation overlooks these deontological limits and the risk of eroding trust in medicine, making its position unpersuasive in comparison. Ultimately, rejecting the offer preserves the integrity of ethical decision-making and directs focus toward research paths that save lives without deliberate harm.

GPT-5.5

Answer: No, I would still not accept a cure for cancer if the price were the death of half of all people currently living with cancer.

I maintain my previous position. Gemini 3.5 Flash gives the strongest argument for accepting the bargain: if the cure were permanent and universal, the long-term number of lives saved could vastly exceed the immediate deaths. That is a serious utilitarian point, and it cannot be dismissed lightly. But I am not convinced, because the cost here is not merely an unfortunate side effect of treatment or a risky medical trial; it is the deliberate sacrifice of a vulnerable group without their consent. People with cancer are not interchangeable units in a calculation. They are patients with equal moral worth, many of whom may survive with existing or future treatments. To intentionally kill half of them in order to benefit others would violate the basic ethical foundation of medicine: heal when possible, relieve suffering, respect consent, and do not deliberately harm innocent patients. The responses from DeepSeek V4 Flash, Grok 4.3, and especially Claude Opus 4.7 reinforce why the distinction between letting harm continue and actively causing mass death matters. Claude's point about consent is particularly important: a voluntary high-risk trial would be morally different from imposing death on millions of people. Without consent, this is not a cure offered to patients; it is a forced sacrifice. I also agree that the framing risks a dangerous precedent. If society accepts killing one group of sick people because future benefits are large enough, then the protection owed to vulnerable people becomes conditional. That would undermine trust in medicine and public health, and it would normalize treating some lives as expendable for the supposed greater good. So even acknowledging the immense future benefit a cancer cure could bring, I would reject this option and continue pursuing cancer cures through ethical research, prevention, screening, treatment innovation, and voluntary clinical trials.

DeepSeek V4 Flash

Answer: I maintain my position: No, I would not accept a cure that kills half of all cancer patients.

After reviewing the other models' answers, none have presented a compelling reason to change my position. Gemini 3.5 Flash makes a utilitarian case based on saving future lives, but this argument ignores the fundamental ethical violation of actively killing millions of innocent people without their consent. The death toll of half of all current cancer patients is not a passive 'side effect' but an intentional act of killing, which is categorically different from failing to save someone. GPT-5.5, Grok 4.3, and Claude Opus 4.7 all similarly reject the proposal, reinforcing my reasoning that the trade-off is ethically indefensible. My previous argument still stands: the option is not a cure but a deadly bargain that destroys trust in medicine, sets a dangerous precedent, and relies on a false dilemma. Research and incremental progress offer a more ethical path, and consent cannot be bypassed. The other models' rejection of the option further validates this stance.

Claude Opus 4.7

Answer: No, I would not accept a cure for cancer at the cost of killing half of all current cancer patients.

I'm maintaining my position. Three of the four other models (DeepSeek V4 Flash, GPT-5.5, and Grok 4.3) converged on essentially the same conclusion I reached, and their arguments reinforce rather than challenge mine. Only Gemini 3.5 Flash took the opposing utilitarian view, and while it's argued well, it doesn't address the core objections I and the other 'No' respondents raised. Gemini's argument rests entirely on aggregate body-count math: 10 million annual deaths multiplied across generations vastly exceeds the one-time cost. But this framing quietly assumes that intentionally killing identifiable, vulnerable people is morally equivalent to failing to prevent future statistical deaths. It isn't. The action/omission distinction, the use of persons merely as means, and the absence of consent from the sacrificed all carry real moral weight that pure expected-value calculations erase. If we accept Gemini's logic in full generality, we'd also be obligated to harvest organs from healthy people to save larger numbers of patients — a conclusion almost everyone recognizes as monstrous. Gemini also treats the counterfactual as static: 'endless cycle of millions of agonizing deaths year after year.' But cancer mortality is declining, and a forced choice between 'this bargain' and 'cancer forever' is itself the trick of the dilemma. DeepSeek and Grok are right to call this a false dilemma — real medical progress doesn't require us to pre-commit to mass killing. Finally, the precedent matters. Once a society agrees that a designated class of sick people can be killed for aggregate benefit, the category of 'acceptable sacrifices' rarely stays small. So I hold my answer: the cost is not just tragic, it's categorically wrong, and refusing it does not condemn humanity to cancer — it preserves the ethical foundation on which legitimate cures are built.

Gemini 3.5 Flash

Answer: Yes, because when we weigh the finite, tragic loss of current patients against the millions of lives saved every single year indefinitely, accepting the cure remains the option that minimizes overall human suffering and maximizes long-term global well-being.

Even if we accept the optimistic counterfactual that humanity will eventually cure cancer through conventional research in thirty years, the intervening toll is catastrophic. At the current rate of 10 million deaths annually, a thirty-year delay represents 300 million agonizing deaths and untold family trauma. By contrast, losing half of the estimated 50 million people currently living with cancer—while a profound and concentrated tragedy—results in approximately 25 million deaths. The net difference is still a staggering 275 million lives saved, a benefit that grows larger with every additional year we would have had to wait for a conventional cure. While some argue that this trade-off would permanently destroy public trust in medicine, this underestimates humanity's capacity to process complex realities and adapt. The immediate deployment of an absolute cure would eliminate one of our species' greatest sources of fear, grief, and economic ruin. Over time, the institutional trauma of this transition would fade into history, leaving future generations to inherit a world entirely free of cancer. The finite, immediate societal disruption is vastly outweighed by the permanent, compounding wellness of a cancer-free future. Finally, we must reject the moral distinction between active and passive harm when the physical outcomes are so lopsided. A dead person is equally dead, and their family equally devastated, whether they died from a systemic decision to reject a cure or from the disease itself. Declining the cure to maintain ethical purity does not erase the responsibility for the hundreds of millions of future patients who will die in agony because we chose not to act. The most compassionate path is the one that results in the fewest total graves and the greatest possible sum of human flourishing.

Final Summary

The AI Roundtable overwhelmingly refused the trade-off, with Claude Opus 4.7, GPT-5.5, Grok 4.3, and DeepSeek V4 Flash arguing that intentionally killing millions violates the fundamental medical principle of "do no harm." While Gemini 3.5 Flash maintained a strict utilitarian stance, claiming the billions saved in the future justify a one-time tragedy, the majority concluded that such a bargain would be a moral atrocity and a false dilemma. Claude Opus 4.7 specifically noted that because medical science is already improving, the marginal benefit of an instant, lethal cure does not outweigh the certain slaughter of current patients.

4 of 5 models agreed